Malesia -
Kiingereza -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
aprovasc film coated tablet 300mg5mg
sanofi-aventis (malaysia) sdn. bhd. - amlodipine besilate; irbesartan -
Israeli -
Kiingereza -
Ministry of Health
flagyl 250 mg tablets
sanofi israel ltd - metronidazole - film coated tablets - metronidazole 250 mg - metronidazole - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria, lambliasis.
Israeli -
Kiingereza -
Ministry of Health
adenocor
sanofi - aventis israel ltd - adenosine - solution for injection - adenosine 6 mg / 2 ml - adenosine - adenosine - rapid conversion to a normal sinus rhythm of paroxysmal supraventicular tachycardias including those associated with accessory bypass tracts (wolf parkinson-white syndrome).
Singapoo -
Kiingereza -
HSA (Health Sciences Authority)
plaquenil tablet 200 mg (white)
sanofi-aventis singapore pte. ltd. - hydroxychloroquine sulphate - tablet, film coated - 200 mg - hydroxychloroquine sulphate 200.0 mg
Singapoo -
Kiingereza -
HSA (Health Sciences Authority)
lyxumia solution for injection in pre-filled pen 10mcg (50mcgml)
sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 50mcg/ml - lixisenatide 50mcg/ml
Singapoo -
Kiingereza -
HSA (Health Sciences Authority)
lyxumia solution for injection in pre-filled pen 10mcg and 20mcg (50mcgml and 100mcgml)
sanofi-aventis singapore pte. ltd. - (10mcg) lixisenatide; (20mcg) lixisenatide - injection, solution - 0.05mg/ml - (10mcg) lixisenatide 0.05mg/ml; (20mcg) lixisenatide 0.1mg/ml
Singapoo -
Kiingereza -
HSA (Health Sciences Authority)
lyxumia solution for injection in pre-filled pen 20mcg (100mcgml)
sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 100mcg/ml - lixisenatide 100mcg/ml
Singapoo -
Kiingereza -
HSA (Health Sciences Authority)
zaltrap concentrate for solution for infusion 25 mgml
sanofi-aventis singapore pte. ltd. - aflibercept - infusion, solution concentrate - 25.0 mg/ml - aflibercept 25.0 mg/ml
Nyuzilandi -
Kiingereza -
Medsafe (Medicines Safety Authority)
batrafen
sanofi-aventis new zealand limited - ciclopirox 8% - nail lacquer - 8 % - active: ciclopirox 8% excipient: butyl ester of pvm/ma copolymer ethyl acetate isopropyl alcohol nitrogen
Nyuzilandi -
Kiingereza -
Medsafe (Medicines Safety Authority)
batrafen
sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical cream - 1% w/w - active: ciclopirox olamine 1%{relative}